Literature DB >> 17126916

The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.

Herbert P M Brok1, Leonie Boven, Marjan van Meurs, Nicole Kerlero de Rosbo, Liesbeth Celebi-Paul, Yolanda S Kap, Anwar Jagessar, Rogier Q Hintzen, Geoff Keir, Jeffrey Bajramovic, Avraham Ben-Nun, Jan Bauer, Jon D Laman, Sandra Amor, Bert A 't Hart.   

Abstract

Rhesus monkeys immunized with MOG(34-56), a dominant T-cell epitope from myelin/oligodendrocyte glycoprotein, develop an acute neurological disease resembling acute disseminated encephalomyelitis (ADEM) in humans. The typical large demyelinated lesions and mononuclear infiltrates in the monkey brains are caused by MOG(34-56) T-cells. We show that MOG(34-56)-reactive CD4+ and CD8+ T-cells are induced in monkeys immunized with a peptide from the human CMV major capsid protein (UL86; 981-1003), that shares sequence similarity with MOG(34-56). Monkeys sensitized against the viral peptide and subsequently challenged with MOG(34-56) display histological signs of encephalitis, but do not show overt neurological signs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126916     DOI: 10.1016/j.jneuroim.2006.10.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

1.  Fatal acute disseminated encephalomyelitis associated with cytomegalovirus infection.

Authors:  Reut Zaguri; Ilan Shelef; Gal Ifergan; Yaniv Almog
Journal:  BMJ Case Rep       Date:  2009-03-17

2.  Deep-coverage rhesus red blood cell proteome: a first comparison with the human and mouse red blood cell.

Authors:  Erica M Pasini; Morten Kirkegaard; Peter Mortensen; Matthias Mann; Alan W Thomas
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Extensive longitudinal myelitis due to cytomegalovirus infection.

Authors:  Rihab Ben Dhia; Mouna Aissi; Mariem Mhiri; Mahbouba Frih Ayed
Journal:  J Neurovirol       Date:  2021-08-27       Impact factor: 2.643

Review 4.  Guillain-Barré syndrome: expanding the concept of molecular mimicry.

Authors:  Jon D Laman; Ruth Huizinga; Geert-Jan Boons; Bart C Jacobs
Journal:  Trends Immunol       Date:  2022-03-04       Impact factor: 19.709

Review 5.  Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development.

Authors:  Yolanda S Kap; Jon D Laman; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-14       Impact factor: 4.147

Review 6.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

7.  Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.

Authors:  S Anwar Jagessar; Nicole Heijmans; Erwin L A Blezer; Jan Bauer; Robert Weissert; Bert A 't Hart
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 8.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

Authors:  Bert A 't Hart; Yvette van Kooyk; Jeroen J G Geurts; Bruno Gran
Journal:  Ann Clin Transl Neurol       Date:  2015-03-18       Impact factor: 4.511

9.  The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.

Authors:  Bert A 't Hart; S Anwar Jagessar; Krista Haanstra; Ernst Verschoor; Jon D Laman; Yolanda S Kap
Journal:  Front Immunol       Date:  2013-06-13       Impact factor: 7.561

10.  Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.

Authors:  Krista G Haanstra; Jacqueline A M Wubben; Margreet Jonker; Bert A 't Hart
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.